In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

Pharmacy Times: Considering Brexanolone for Postpartum Depression

In March 2019, the FDA approved the brexanolone (Zulresso, Sage Therapeutics) injection for intravenous (IV) use for the treatment of PPD in adult women. This was the first drug approved by the FDA specifically for this disorder. read more

Daily Camera: Louisville’s GHX acquires Chicago-based health-data company

The Lumere acquisition extends GHX’s footprint in the pharmaceutical market, helping health systems manage pharmacy costs. Lumere has developed a data and analytics engine that helps organizations understand the best products to use on the best patients, at the right time. read more

Chicago Inno: Chicago Startup Lumere Acquired By Colorado Healthtech Company

Global Healthcare Exchange announced on January 13 that it acquired Lumere for an undisclosed amount. Founded in 2012, Lumere provides data and analytics to help healthcare organizations build clinically-integrated supply chains and optimize medication formularies. read more

HIT Consultant: GHX Acquires Lumere to Advance Clinically Integrated Supply Chains

Global Healthcare Exchange (GHX) announced it has acquired Lumere. As reimbursement models move to fee-for-value, GHX believes Lumere’s capabilities will extend its value to more directly improve patient outcomes at the lowest cost by empowering customers to make evidence-based purchasing and utilization decisions. read more

Managed Healthcare Executive: Three Experts Share Formulary Management Advice

Formulary management activities are an essential component for effectively managing medication utilization, according to experts. read more

Pharmacy Practice News: ABx Stewardship: Another Deadline To Worry About!

An estimated 15% of the nation’s hospitals have not met the impending Centers for Medicare & Medicaid Services (CMS) conditions of participation to implement an effective antibiotic stewardship program (ASP) by March 30, 2020, according to the CDC. read more

Patient Safety & Quality Healthcare: What You Need to Know About CMS’ Antimicrobial Stewardship Rule

On September 26, 2019, CMS released revised Conditions of Participation for hospitals and critical access hospitals that require the development and implementation of antimicrobial stewardship programs. Lumere experts share their thoughts on the new regulations and what measures healthcare facilities should be putting in place. read more

Becker’s ASC: Robotics might not be worth the ‘tremendous’ investment for ASCs — 2 leaders explain why

ASCs considering introducing robotics should seriously examine whether it's worth the major investment, according to Lumere Chief Medical Officer John Cherf, MD. Dr. Cherf and Lumere Category Adviser Simon Kerr shared their thoughts on robotics with Becker's ASC Review. read more

Becker’s Hospital Review: Larger chunk of hospital drug spending going toward cancer treatments, study finds

An analysis by Lumere, a research and analytics firm that focuses on hospitals, looked at how 26 hospitals from four health systems across the country spent their drug budgets this year. The research found some hospitals are spending a larger chunk of their budgets on new treatments for cancer and migraines, as well as to prevent white cell depletion in chemotherapy patients. read more